Request Legal Help Now - Free
LAWSUITS NEWS & LEGAL INFORMATION

Drugs/Medical Legal News Articles & Interviews

View Lawyer Interviews only

Johnson & Johnson Settles Deceptive Hip Implant Marketing Lawsuits for $120 Million

Johnson & Johnson Settles Deceptive Hip Implant Marketing Lawsuits for $120 Million February 12, 2019. By Anne Wallace.
Washington, DC Johnson & Johnson (“J&J”) has agreed to pay $120 million to the attorneys general of 46 states and Washington, D.C. to settle claims that the company made unfair and deceptive statements in the promotion of its ASR XL and Pinnacle Ultamet hip implant systems. A separate agreement is expected to resolve most of the thousands of consumer-driven defective hip implant lawsuits against J&J and its DePuy unit.
Read [ Johnson & Johnson Settles Deceptive Hip Implant Marketing Lawsuits for $120 Million ]

Discrepancies in Emergency Room Overcharges Cause Frustration and Financial Woes

Discrepancies in Emergency Room Overcharges Cause Frustration and Financial Woes February 11, 2019. By Jane Mundy.
Scottsdale, AZ: Emergency room care in the US is the highest-priced care a patient can receive. Even a minor condition can set you back thousands of dollars, which in itself can cause health issues—financial problems are stressful. It can get worse: one patient dinged with outrageous emergency room overcharges later discovered that another patient with similar treatment paid a lot less.
Read [ Discrepancies in Emergency Room Overcharges Cause Frustration and Financial Woes ]

ER Charges: Underserved and Over-Charged thanks to Upcoding

ER Charges: Underserved and Over-Charged thanks to Upcoding January 10, 2019. By Jane Mundy.
Los Angeles, CA: When a nine-year old accidentally had gasoline splashed in her eyes, her mother immediately drove her to the closest hospital emergency room. They were directed to the eyewash station but it was so dirty they couldn’t use it, so Brianna’s mom rinsed her daughter’s eyes at a regular sink. Turns out, they would have been better off using the gas station’s eyewash, which was free. The ER sink cost $1,400: the hospital charged $600 and the ER doctor fee was $800 (for walking into the room, saying Brianna needed an eyewash station and walking out). Upcoding has become common practice, resulting in emergency room overcharges and increased health costs for everyone.
Read [ ER Charges: Underserved and Over-Charged thanks to Upcoding ]

Amputees Fighting for Insurance Coverage Get Tips from Blue Cross Antitrust Lawsuit

Amputees Fighting for Insurance Coverage Get Tips from Blue Cross Antitrust Lawsuit September 20, 2018. By Anne Wallace.
Wilmington, DE As amputees fight for insurance coverage for advanced, microprocessor- assisted prostheses, it can help to look at other insurance lawsuits that describe a similar pattern of claims denials.
Read [ Amputees Fighting for Insurance Coverage Get Tips from Blue Cross Antitrust Lawsuit ]

Valsartan Recall Lawsuits Filed over Alleged Carcinogenic Contaminants

Valsartan Recall Lawsuits Filed over Alleged Carcinogenic Contaminants September 17, 2018. By Anne Wallace.
Washington, DC On August 27, 2018, the Food and Drug Administration published updated press information that expands its original July 17 valsartan recall notice. Sixteen companies have now announced voluntary recalls of blood pressure and heart medications.
Read [ Valsartan Recall Lawsuits Filed over Alleged Carcinogenic Contaminants ]

Amputees’ Fight for Insurance Coverage Focuses on ‘Medical Necessity’ of Microprocessor Prosthetics

Amputees’ Fight for Insurance Coverage Focuses on ‘Medical Necessity’ of Microprocessor Prosthetics September 4, 2018. By Anne Wallace.
Washington, DC Lucky to live, unlucky to lose a foot or a leg, survivors of the Boston Marathon bombing soon found themselves facing the harsh truth of inadequate insurance coverage for their prosthetic care. Years on, the good news is that microprocessor-enhanced artificial limbs have gotten better. The bad news is that insurance companies like Anthem and United Healthcare still balk at paying for them. Insurance lawsuits since then have taken particular aim at the internal review standards insurers use to determine whether a medical treatment or device is “medically necessary.” The standards do not line up with what amputees need most and what these modern devices can really do. Cost cutting vs. good health – it’s the match of the century.
Read [ Amputees’ Fight for Insurance Coverage Focuses on ‘Medical Necessity’ of Microprocessor Prosthetics ]

Anthem Denials of Emergency Room CT Scans and MRIs; Patients Sent to Clinics

Anthem Denials of Emergency Room CT Scans and MRIs; Patients Sent to Clinics August 6, 2018. By Anne Wallace.
Washington, DC In July 2018, the American College of Emergency Physicians filed an insurance lawsuit against Anthem Blue Cross Blue Shield over the insurer’s new policy of denying emergency room coverage after the fact. As a subpart of the strategy, Anthem refuses claims for in-hospital CT scans and MRIs ordered in the course of emergency diagnosis and treatment. The lawsuit focuses on the harm the policy does to patients. But it also shines a light on the damage that Anthem’s plan does to hospitals and the wider healthcare system.
Read [ Anthem Denials of Emergency Room CT Scans and MRIs; Patients Sent to Clinics ]

Essure’s Shelf Life in the US Soon to Expire

Essure’s Shelf Life in the US  Soon to Expire July 24, 2018. By Jane Mundy.
Bayer says it will no longer sell Essure in the U.S. due to decline in sales. Bayer doesn’t say, however, that its decision comes after the FDA threatened the drug giant with civil and criminal penalties if it didn’t warn patients about adverse Essure side effects.
Read [ Essure’s Shelf Life in the US Soon to Expire ]

Study Further Links Proton Pump Inhibitors to Gastric Cancer and Conflicts with FDA study, Lawsuits to Follow

Study Further Links Proton Pump Inhibitors to Gastric Cancer and Conflicts with FDA study, Lawsuits to Follow May 31, 2018. By Jane Mundy.
Santa Clara, CA: A link between proton pump inhibitors (PPIs) and high risk of gastric cancer isn’t new, but the results of a new study conflicts with the FDA’s mandated PPI study.
Read [ Study Further Links Proton Pump Inhibitors to Gastric Cancer and Conflicts with FDA study, Lawsuits to Follow ]

More Type 2 Diabetics add Complaints to Ongoing Onglyza Litigation

More Type 2 Diabetics add Complaints to Ongoing Onglyza Litigation April 4, 2018. By Jane Mundy.
Atlanta, GA: In the past month, two more Onglyza and Kombiglyze lawsuits were filed on behalf of diabetes patients who claim the manufacturer concealed information linking the diabetes drug to an increased risk of heart failure and failed to warn about its alleged potential to cause serious heart problems.
Read [ More Type 2 Diabetics add Complaints to Ongoing Onglyza Litigation ]

Page: 1  2  3  4  5  6  7  8  9  -  10»  -  100»  -  124   Next»
Request Legal Help Now! - Free